Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.

Dual Strands of Pre-miR-149 Inhibit Cancer Cell Migration and Invasion through Targeting FOXM1 in Renal Cell Carcinoma.

Okato A, Arai T, Yamada Y, Sugawara S, Koshizuka K, Fujimura L, Kurozumi A, Kato M, Kojima S, Naya Y, Ichikawa T, Seki N.

Int J Mol Sci. 2017 Sep 13;18(9). pii: E1969. doi: 10.3390/ijms18091969.

2.

Regulation of spindle and kinetochore-associated protein 1 by antitumor miR-10a-5p in renal cell carcinoma.

Arai T, Okato A, Kojima S, Idichi T, Koshizuka K, Kurozumi A, Kato M, Yamazaki K, Ishida Y, Naya Y, Ichikawa T, Seki N.

Cancer Sci. 2017 Jul 26. doi: 10.1111/cas.13331. [Epub ahead of print]

3.

Impact of novel miR-145-3p regulatory networks on survival in patients with castration-resistant prostate cancer.

Goto Y, Kurozumi A, Arai T, Nohata N, Kojima S, Okato A, Kato M, Yamazaki K, Ishida Y, Naya Y, Ichikawa T, Seki N.

Br J Cancer. 2017 Jul 25;117(3):409-420. doi: 10.1038/bjc.2017.191. Epub 2017 Jun 22.

PMID:
28641312
4.

Regulation of ITGA3 by the anti-tumor miR-199 family inhibits cancer cell migration and invasion in head and neck cancer.

Koshizuka K, Hanazawa T, Kikkawa N, Arai T, Okato A, Kurozumi A, Kato M, Katada K, Okamoto Y, Seki N.

Cancer Sci. 2017 Aug;108(8):1681-1692. doi: 10.1111/cas.13298. Epub 2017 Jul 4.

5.

Dual strands of pre-miR‑150 (miR‑150‑5p and miR‑150‑3p) act as antitumor miRNAs targeting SPOCK1 in naïve and castration-resistant prostate cancer.

Okato A, Arai T, Kojima S, Koshizuka K, Osako Y, Idichi T, Kurozumi A, Goto Y, Kato M, Naya Y, Ichikawa T, Seki N.

Int J Oncol. 2017 Jul;51(1):245-256. doi: 10.3892/ijo.2017.4008. Epub 2017 May 17.

PMID:
28534948
6.

The tumor-suppressive microRNA-23b/27b cluster regulates the MET oncogene in oral squamous cell carcinoma.

Fukumoto I, Koshizuka K, Hanazawa T, Kikkawa N, Matsushita R, Kurozumi A, Kato M, Okato A, Okamoto Y, Seki N.

Int J Oncol. 2016 Sep;49(3):1119-29. doi: 10.3892/ijo.2016.3602. Epub 2016 Jul 4.

PMID:
27573718
7.

Regulation of metastasis-promoting LOXL2 gene expression by antitumor microRNAs in prostate cancer.

Kato M, Kurozumi A, Goto Y, Matsushita R, Okato A, Nishikawa R, Fukumoto I, Koshizuka K, Ichikawa T, Seki N.

J Hum Genet. 2017 Jan;62(1):123-132. doi: 10.1038/jhg.2016.68. Epub 2016 Jun 9.

PMID:
27278788
8.

Direct regulation of LAMP1 by tumor-suppressive microRNA-320a in prostate cancer.

Okato A, Goto Y, Kurozumi A, Kato M, Kojima S, Matsushita R, Yonemori M, Miyamoto K, Ichikawa T, Seki N.

Int J Oncol. 2016 Jul;49(1):111-22. doi: 10.3892/ijo.2016.3522. Epub 2016 May 16.

9.

Regulation of E3 ubiquitin ligase-1 (WWP1) by microRNA-452 inhibits cancer cell migration and invasion in prostate cancer.

Goto Y, Kojima S, Kurozumi A, Kato M, Okato A, Matsushita R, Ichikawa T, Seki N.

Br J Cancer. 2016 May 10;114(10):1135-44. doi: 10.1038/bjc.2016.95. Epub 2016 Apr 12.

10.

Regulation of the collagen cross-linking enzymes LOXL2 and PLOD2 by tumor-suppressive microRNA-26a/b in renal cell carcinoma.

Kurozumi A, Kato M, Goto Y, Matsushita R, Nishikawa R, Okato A, Fukumoto I, Ichikawa T, Seki N.

Int J Oncol. 2016 May;48(5):1837-46. doi: 10.3892/ijo.2016.3440. Epub 2016 Mar 15.

11.

Tumor-suppressive microRNA-29 family inhibits cancer cell migration and invasion directly targeting LOXL2 in lung squamous cell carcinoma.

Mizuno K, Seki N, Mataki H, Matsushita R, Kamikawaji K, Kumamoto T, Takagi K, Goto Y, Nishikawa R, Kato M, Enokida H, Nakagawa M, Inoue H.

Int J Oncol. 2016 Feb;48(2):450-60. doi: 10.3892/ijo.2015.3289. Epub 2015 Dec 14.

12.

Tumor-suppressive microRNA-223 inhibits cancer cell migration and invasion by targeting ITGA3/ITGB1 signaling in prostate cancer.

Kurozumi A, Goto Y, Matsushita R, Fukumoto I, Kato M, Nishikawa R, Sakamoto S, Enokida H, Nakagawa M, Ichikawa T, Seki N.

Cancer Sci. 2016 Jan;107(1):84-94. doi: 10.1111/cas.12842. Epub 2015 Dec 5.

13.

Tumor-suppressive microRNAs (miR-26a/b, miR-29a/b/c and miR-218) concertedly suppressed metastasis-promoting LOXL2 in head and neck squamous cell carcinoma.

Fukumoto I, Kikkawa N, Matsushita R, Kato M, Kurozumi A, Nishikawa R, Goto Y, Koshizuka K, Hanazawa T, Enokida H, Nakagawa M, Okamoto Y, Seki N.

J Hum Genet. 2016 Feb;61(2):109-18. doi: 10.1038/jhg.2015.120. Epub 2015 Oct 22.

PMID:
26490187
14.

MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker.

Goto Y, Kojima S, Nishikawa R, Kurozumi A, Kato M, Enokida H, Matsushita R, Yamazaki K, Ishida Y, Nakagawa M, Naya Y, Ichikawa T, Seki N.

Br J Cancer. 2015 Sep 29;113(7):1055-65. doi: 10.1038/bjc.2015.300. Epub 2015 Sep 1.

15.

MicroRNA-26a/b directly regulate La-related protein 1 and inhibit cancer cell invasion in prostate cancer.

Kato M, Goto Y, Matsushita R, Kurozumi A, Fukumoto I, Nishikawa R, Sakamoto S, Enokida H, Nakagawa M, Ichikawa T, Seki N.

Int J Oncol. 2015 Aug;47(2):710-8. doi: 10.3892/ijo.2015.3043. Epub 2015 Jun 10.

PMID:
26063484
16.

Management of men with a suspicion of prostate cancer after negative initial prostate biopsy results.

Yamamoto S, Kato M, Tomiyama Y, Amiya Y, Sasaki M, Shima T, Suzuki N, Murakami S, Nakatsu H, Shimazaki J.

Urol Int. 2014;92(3):258-63. doi: 10.1159/000355355. Epub 2014 Mar 12.

17.

Expression of transcription factor Snai1 and tubulointerstitial fibrosis in progressive nephropathy.

Ohnuki K, Umezono T, Abe M, Kobayashi T, Kato M, Miyauchi M, Yamamoto N, Kimura M, Toyoda M, Suzuki D.

J Nephrol. 2012 Mar-Apr;25(2):233-9. doi: 10.5301/JN.2011.8449.

PMID:
21725924
18.

Assessment of Growth Disturbance in Japanese Children with IBD.

Shono T, Kato M, Aoyagi Y, Haruna H, Fujii T, Kudo T, Ohtsuka Y, Shimizu T.

Int J Pediatr. 2010;2010:958915. doi: 10.1155/2010/958915. Epub 2010 May 5.

19.

Hypertrophy and loss of podocytes in diabetic nephropathy.

Miyauchi M, Toyoda M, Kobayashi K, Abe M, Kobayashi T, Kato M, Yamamoto N, Kimura M, Umezono T, Suzuki D.

Intern Med. 2009;48(18):1615-20. Epub 2009 Sep 15.

20.

Mitochondrial DNA variants in a Japanese population of patients with Alzheimer's disease.

Tanaka N, Goto Y, Akanuma J, Kato M, Kinoshita T, Yamashita F, Tanaka M, Asada T.

Mitochondrion. 2010 Jan;10(1):32-7. doi: 10.1016/j.mito.2009.08.008. Epub 2009 Aug 22.

PMID:
19703591

Supplemental Content

Loading ...
Support Center